NEW FORMULATIONS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE

摘要

The invention relates to the use of at least one quantitative ratio (quotient) of two amyloid beta peptidea (A beta; Aß) which are different from one another in a sample of a bodily fluid of a test subject and/or patient in order to determine the probability (risk) of said test subject and/or patient suffering Alzheimer's disease (Morbus Alzheimer, AD) and/or to determine (diagnose) suffering from an early stage of Alzheimer's disease, wherein the amyloid beta peptides are selected from (a) Aß(1-42), (b) Aß(2-40) and (c) Aß(2-42) and wherein the quantitative ratio of (a) / (b) or vice versa and/or of (a) / (c) or vice versa is formed. The invention also relates to a corresponding method and to a kit for use in this connection.